CoChat

Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Utrophin is highly homologous and structurally similar to dystrophin, and in gene delivery experiments in mdx mice was able to functionally replace dystrophin. We performed mini-utrophin gene transfer in Golden Retriever dogs with canine muscular dystrophy (CXMD). Unlike the mouse model, the clinicopathological phenotype of CXMD is similar to that of Duchenne muscular dystrophy (DMD). We injected an adenoviral vector expressing a synthetic utrophin into tibialis anterior muscles of newborn dogs affected with CXMD and examined transgene expression by RNA and protein analysis at 10, 30 and 60 days postinjection in cyclosporin-treated and -untreated animals. Immunosuppression by cyclosporin was required to mitigate the immune response to viral and transgene antigens. RT-PCR analysis showed the presence of the exogenous transcript in the muscle of cyclosporin-treated and -untreated animals. The transgenic utrophin was efficiently expressed at the extrajunctional membrane in immunosuppressed dogs and this expression was stable for at least 60 days. We found reduced fibrosis and increased expression of dystrophin-associated proteins (DAPs) in association with muscle areas expressing the utrophin minigene, indicating that mini-utrophin can functionally compensate for lack of dystrophin in injected muscles. For this reason, utrophin transfer to dystrophin-deficient muscle appears as a promising therapeutic approach to DMD.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.gt.3301941

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 127

Metadata

Authors
Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K. E., Cornelio, F., Pozza, O., Karpati, G., Gilbert, R., & Mora, M.
Affiliations
  • Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
  • University of Milan (IT)
  • University of Oxford (GB)
  • Montreal Neurological Institute and Hospital (CA)
Venue
Gene Therapy
Published
2003-04-17
Volume
10
Issue
9
Pages
750-757
ISSN
  • 0969-7128 (ISSN-L)
  • 1476-5462
OpenAlex
W2080701229
Cited by
126
References
33
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 8
FWCI
2.41
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • NPARC (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Keywords
utrophin, adenoviral vector, Duchenne muscular dystrophy, dystrophin-associated proteins, muscle fibrosis
MeSH terms
Adenoviridae, Animals, Cytoskeletal Proteins, Dog Diseases, Dogs, Female, Fibrosis, Genetic Vectors, Immunohistochemistry, Immunosuppressive Agents, Male, Membrane Proteins, Muscular Dystrophy, Animal, Transduction, Genetic, Genetic Therapy, Gene Expression, Dystrophin, Cyclosporine, Muscle, Skeletal, CD4 Lymphocyte Count, Transgenes, Muscular Dystrophy, Duchenne, Models, Animal, Utrophin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. https://app.cochat.ai/papers/10.1038/sj.gt.3301941
The paper
Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K. E., Cornelio, F., Pozza, O., Karpati, G., Gilbert, R., & Mora, M. (2003). Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Therapy. https://doi.org/10.1038/sj.gt.3301941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.